Background: Ischemic heart disease (IHD) is a leading cause of mortality and morbidity in patients with COPD. The contribution of IHD to acute outcomes in patients with acute exacerbation of COPD (AECOPD) is not known in detail. The present study assessed the effect of comorbid IHD on length of stay (LOS), risk of intensive care unit (ICU) admission and death as indicators of the shortterm outcomes for patients hospitalized for AECOPD. Materials and Methods: Medical records of patients hospitalized for AECOPD from September 2008 to March 2014 were reviewed. Data extracted from patient records regarding the presence of comorbidities and the markers of disease severity were analyzed using logistic regression for ICU admission and mortality, the Kaplan-Meier method, log rank test and Cox regression for LOS. Results: Of 507 separate admissions, 146 episodes (28.8%) occurred in patients with IHD. The median LOS was 7 days [interquartile range (IQR) 6, 11] in patients with IHD versus 6 days (IQR 5, 8) for patients without IHD. After adjustment for confounders, LOS was found to be 26% longer (p=0.033) for patients with IHD. The adjusted odds ratio for the risk of ICU admission and death in patients with IHD was 2.97 and 3.86, respectively. Conclusion: Patients hospitalized for AECOPD with comorbid IHD had longer LOS, greater risk for ICU admission and death. It seems that this group is a particular COPD subtype with a more severe degree of COPD and poorer acute outcomes that may influence optimal management.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide (1) . It affects more than 5% of the population (2) . As a result of its high incidence and chronicity, COPD results in frequent hospitalizations for acute exacerbations, high resource utilization with numerous physician visits, and the need for chronic therapy (3) . Comorbidities may diminish survival rates in patients with COPD, are often underrecognized and under-treated and can frequently result in death independent of respiratory failure (4-7).
Considerable research has been undertaken and clinical
interest exists about the extra-pulmonary manifestations and comorbid conditions related to COPD. The extent to which comorbidities contribute to COPD severity has not yet been well realized (8) . Cardiovascular, musculoskeletal and psychological conditions are among the most prevalent comorbidities. In particular, IHD is a major cause of mortality and morbidity in the COPD population as a whole (9) .
TANAFFOS 166 Ischemic Heart Disease and COPD Exacerbations
Tanaffos 2015; 14 (3) : [165] [166] [167] [168] [169] [170] [171] Ischemic heart disease and its complications (myocardial infarction, heart failure, arrhythmia) are common in patients with COPD and may be more prevalent than predicted for shared risk factors such as smoking and aging (10, 11) . These could be linked to systemic inflammation (12) . The presence of IHD may help predict survival and hospitalization (8) .
Exacerbations of COPD are defined as episodes of increased dyspnea and cough and changes in the amount and character of sputum (1) ischemic heart disease.
MATERIALS AND METHODS

This
The median LOS was 7 days (IQR 6, 11) in patients with Table 3 . There were a few deaths in the study (10/146; 6.8%) among patients with IHD (7/361; 1.9% among patients without IHD); however, the risk of death in patients with IHD was greater than the risk of death in patients without IHD. The crude OR for the risk of death was 3.72 (95% CI:
1.4-9.98, P=0.009) and the adjusted OR was 3.86 (95% CI:
1.37-10.09) in patients with IHD.
DISCUSSION
The results of this study showed that patients (16) (17) (18) . Based on these data, COPD patients with increased comorbidities, cardiovascular disorders and systemic inflammation can be considered as a subtype identified in recently published studies as "systemic COPD" (19) or "subtype C" (20) ; although the degree of severity of COPD in these patients remains controversial (11, 14, 21, 22 (25) . While the current study adjusted for most of these confounders, our results indicated that IHD could be considered as a prognostic factor for acute outcomes of patients hospitalized for AECOPD.
Comorbidity rates in the current study and those reported elsewhere were the same, with the exception of dyslipidemia, which was lower in our study in comparison with previous studies (4, 5, 14, 15) . One explanation for this finding could be differences in race, lifestyle and obesity in the studied population.
The strength of this study was the inclusion of markers for disease severity that were not measured by Silver et al, 
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